LANVIS Side Effects

6782062-X | T-cell Lymphoma
on Jun 08, 2010 Female patient from NETHERLANDS , weighting 13.23 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Lanvis (View Usage). Patient experienced the following unwanted or unexpected effects: t-cell lymphoma. Lanvis dosage: 20mg Per Day. During the same period patient was treated with FEROGRADUMET (105mg Per Day) (View Ferogradumet Review and Ferogradumet Label ), HYDROCOBAMINE (View Hydrocobamine Review and Hydrocobamine Label ).

6761078-3 | T-cell Lymphoma
Patient was taking Lanvis (View Usage). Patient had the following side effects: t-cell lymphoma on Jun 01, 2010 from NETHERLANDS Additional patient health information: Female patient , weighting 13.23 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Lanvis dosage: 20mg Per Day.

6575613-1 | Bone Marrow Failure, Haemolytic Uraemic Syndrome, Hepatotoxicity, Pancreatitis
Adverse event was reported on Jan 29, 2010 by a Female patient taking Lanvis (View Usage) (Dosage: ) . Location: FRANCE , weighting 50.71 lb, After Lanvis was administered, patient had the following side effects: bone marrow failure, haemolytic uraemic syndrome, hepatotoxicity, pancreatitis. During the same period patient was treated with PURINETHOL (View Purinethol Review and Purinethol Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), BACTRIM (400mg Three Times Per Week) (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

6539544-5 | Bone Marrow Failure, Haemolytic Uraemic Syndrome, Hepatotoxicity, Pancreatitis
on Jan 05, 2010 Female patient from FRANCE , child 8 years of age, was treated with Lanvis (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, haemolytic uraemic syndrome, hepatotoxicity, pancreatitis. Lanvis dosage: . During the same period patient was treated with PURINETHOL (View Purinethol Review and Purinethol Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.


6449026-7 | Blood Culture Positive, Bone Marrow Failure
on Nov 12, 2009 Male patient from FRANCE , weighting 17.64 lb, was treated with Lanvis (View Usage). Patient had the following side effects: blood culture positive, bone marrow failure. Lanvis dosage: 20mg Per Day. During the same period patient was treated with VINCRISTINE (400mcg Weekly) (View Vincristine Review and Vincristine Label ), CERUBIDINE (8500mcg Weekly) (View Cerubidine Review and Cerubidine Label ), CYTARABINE (21mg Per Day) (View Cytarabine Review and Cytarabine Label ), KIDROLASE (678iu Single Dose) (View Kidrolase Review and Kidrolase Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), METHYLPREDNISOLONE 4MG TAB (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6121116-8 | Haemochromatosis, Hepatic Neoplasm, Hepatocellular Injury
Patient was taking Lanvis (View Usage). After Lanvis was administered, patient had the following side effects: haemochromatosis, hepatic neoplasm, hepatocellular injury on Mar 13, 2009 from BRAZIL Additional patient health information: Female patient , 14 years of age, weighting 110.2 lb, . Lanvis dosage: . During the same period patient was treated with BLOOD TRANSFUSION (View Blood Transfusion Review and Blood Transfusion Label ).

6100011-4 | Hepatic Neoplasm
Adverse event was reported on Feb 27, 2009 by a Female patient taking Lanvis (View Usage) (Dosage: ) . Location: BRAZIL , 14 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: hepatic neoplasm.

5993972-5 | Eye Pain, Optic Neuritis, Visual Acuity Reduced
on Dec 04, 2008 Female patient from FRANCE , 42 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Lanvis (View Usage). Patient had the following side effects: eye pain, optic neuritis, visual acuity reduced. Lanvis dosage: 1.5unit Per Day. During the same period patient was treated with REMICADE (View Remicade Review and Remicade Label ). Patient was hospitalized.

5978592-0 | Erythema, Pancytopenia, Purpura, Subcutaneous Abscess
on Nov 24, 2008 Female patient from FRANCE , 48 years of age, was diagnosed with crohn's disease (What is crohn's disease?), vitamin b12 deficiency, blood folate decreased and was treated with Lanvis (View Usage). After Lanvis was administered, patient had the following side effects: erythema, pancytopenia, purpura, subcutaneous abscess. Lanvis dosage: 20mg Per Day. During the same period patient was treated with B12 VITAMIN (1000mcg Weekly) (View B12 Vitamin Review and B12 Vitamin Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ). Patient was hospitalized.

5822965-3 | Ascites, Blood Bilirubin Increased, Hepatomegaly, Jaundice, Pleural Effusion, Venoocclusive Liver Disease
Patient was taking Lanvis (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, blood bilirubin increased, hepatomegaly, jaundice (What is jaundice?), pleural effusion, venoocclusive liver disease on Jul 18, 2008 from CANADA Additional patient health information: Male patient , child 3 years of age, . Lanvis dosage: 40mg Per Day. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ALBUMIN (HUMAN) (View Albumin (human) Review and Albumin (human) Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DEFIBROTIDE (View Defibrotide Review and Defibrotide Label ), DIMENHYDRINATE (View Dimenhydrinate Review and Dimenhydrinate Label ), METHOTREXATE SODIUM (View Methotrexate Sodium Review and Methotrexate Sodium Label ), MORPHINE (View Morphine Review and Morphine Label ).

5358900-4 | Contusion, Petechiae, Thrombocytopenic Purpura
Adverse event was reported on Jun 12, 2007 by a Female patient taking Lanvis (View Usage) (Dosage: ) . Location: CANADA , child 10 years of age, Patient had the following side effects: contusion, petechiae, thrombocytopenic purpura. During the same period patient was treated with PURINETHOL (View Purinethol Review and Purinethol Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DAUNOMYCIN (View Daunomycin Review and Daunomycin Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ).

5358899-0 | Contusion, Petechiae, Thrombocytopenia, Thrombocytopenic Purpura
on Jun 12, 2007 Male patient from CANADA , 16 years of age, was treated with Lanvis (View Usage). After Lanvis was administered, patient had the following side effects: contusion, petechiae, thrombocytopenia, thrombocytopenic purpura. Lanvis dosage: . During the same period patient was treated with PURINETHOL (View Purinethol Review and Purinethol Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DAUNOMYCIN (View Daunomycin Review and Daunomycin Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ), ELSPAR (View Elspar Review and Elspar Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ).

5319120-2 | Abdominal Distension, Ascites, Hepatomegaly, Oedema Peripheral, Transaminases Increased
on Apr 27, 2007 Female patient from FRANCE , child 5 years of age, weighting 44.09 lb, was diagnosed with prophylaxis and was treated with Lanvis (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, ascites, hepatomegaly, oedema peripheral, transaminases increased. Lanvis dosage: 46mg Per Day. During the same period patient was treated with ZOFRAN (4mg Cyclic) (View Zofran Review and Zofran Label ), CYTARABINE (23.2mg Cyclic) (View Cytarabine Review and Cytarabine Label ), ETOPOPHOS (115mg Per Day) (View Etopophos Review and Etopophos Label ), LEDERTREXATE (12mg Per Day) (View Ledertrexate Review and Ledertrexate Label ), FORTUM (View Fortum Review and Fortum Label ), AMIKLIN (View Amiklin Review and Amiklin Label ), TARGOCID (View Targocid Review and Targocid Label ). Patient was hospitalized.

5311540-5 | Blood Iron Increased, Blood Lactate Dehydrogenase Increased, Histiocytosis Haematophagic, Inflammation, Pancytopenia, Peritoneal Effusion, Petechiae, Pyrexia, Retinal Haemorrhage
Patient was taking Lanvis (View Usage). Patient had the following side effects: blood iron increased, blood lactate dehydrogenase increased, histiocytosis haematophagic, inflammation, pancytopenia, peritoneal effusion, petechiae, pyrexia, retinal haemorrhage on Apr 17, 2007 from FRANCE Additional patient health information: Male patient , child 7 years of age, . Lanvis dosage: 60mg Per Day. During the same period patient was treated with ARACYTINE (30mg Four Times Per Day) (View Aracytine Review and Aracytine Label ), ENDOXAN (1g Twice Per Day) (View Endoxan Review and Endoxan Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

5177056-4 | Abdominal Distension, Abdominal Pain Upper, Ascites, Coagulopathy, Hepatocellular Damage, Hepatomegaly, Portal Hypertension, Venoocclusive Liver Disease, Weight Increased
Adverse event was reported on Dec 05, 2006 by a Female patient taking Lanvis (View Usage) (Dosage: ) was diagnosed with lymphocytic leukaemia and. Location: FRANCE , child 5 years of age, weighting 65.48 lb, After Lanvis was administered, patient had the following side effects: abdominal distension, abdominal pain upper, ascites, coagulopathy, hepatocellular damage, hepatomegaly, portal hypertension, venoocclusive liver disease, weight increased. During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), ARACYTINE (View Aracytine Review and Aracytine Label ). Patient was hospitalized.

5177038-2 | Abdominal Distension, Abdominal Pain, Ascites, Coagulopathy, Cough, Haemorrhagic Disorder, Hepatic Pain, Hepatic Vein Stenosis
on Oct 18, 2006 Male patient from FRANCE , child 5 years of age, weighting 44.09 lb, was diagnosed with lymphocytic leukaemia and was treated with Lanvis (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain (What is abdominal pain?), ascites, coagulopathy, cough, haemorrhagic disorder, hepatic pain, hepatic vein stenosis. Lanvis dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), ARACYTINE (View Aracytine Review and Aracytine Label ). Patient was hospitalized.

5177037-0 | Abdominal Distension, Ascites, Febrile Bone Marrow Aplasia, Haemorrhagic Disorder, Hepatic Pain, Hepatomegaly, Jaundice, Pallor, Pleural Effusion
on Oct 18, 2006 Male patient from FRANCE , child 3 years of age, weighting 28.66 lb, was diagnosed with lymphocytic leukaemia and was treated with Lanvis (View Usage). Patient had the following side effects: abdominal distension, ascites, febrile bone marrow aplasia, haemorrhagic disorder, hepatic pain, hepatomegaly, jaundice (What is jaundice?), pallor, pleural effusion. Lanvis dosage: . During the same period patient was treated with ENDOXAN (1gm2 Per Day) (View Endoxan Review and Endoxan Label ), ARACYTINE (75mgm2 Per Day) (View Aracytine Review and Aracytine Label ). Patient was hospitalized.

5177035-7 | Abdominal Distension, Aplasia, Ascites, Hepatic Pain, Hepatocellular Damage, Hepatomegaly, Pallor, Pleural Effusion, Prothrombin Level Decreased
Patient was taking Lanvis (View Usage). After Lanvis was administered, patient had the following side effects: abdominal distension, aplasia, ascites, hepatic pain, hepatocellular damage, hepatomegaly, pallor, pleural effusion, prothrombin level decreased on Oct 18, 2006 from FRANCE Additional patient health information: Female patient , child 7 years of age, weighting 35.27 lb, was diagnosed with lymphocytic leukaemia and. Lanvis dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), ARACYTINE (View Aracytine Review and Aracytine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

5031570-0 | Anaemia, Diarrhoea Haemorrhagic, Neutropenia, Pancytopenia, Thrombocytopenia
Adverse event was reported on Mar 22, 2004 by a Male patient taking Lanvis (View Usage) (Dosage: 160mg Per Day) . Location: FRANCE , 63 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, diarrhoea haemorrhagic, neutropenia, pancytopenia, thrombocytopenia. Patient was hospitalized.

5031569-4 | Anaemia, Bacterial Infection, C-reactive Protein Increased, Diarrhoea Haemorrhagic, Dysplasia, Leukopenia, Neutropenia, Pancytopenia, Petechiae
on Oct 15, 2003 Male patient from FRANCE , 63 years of age, was diagnosed with prophylaxis and was treated with Lanvis (View Usage). Patient had the following side effects: anaemia, bacterial infection (What is bacterial infection?), c-reactive protein increased, diarrhoea haemorrhagic, dysplasia, leukopenia, neutropenia, pancytopenia, petechiae. Lanvis dosage: 80mg Twice Per Day. During the same period patient was treated with FLAGYL (500mg Twice Per Day) (View Flagyl Review and Flagyl Label ), PROCTOLOG (1sup Twice Per Day) (View Proctolog Review and Proctolog Label ), SELOKEN (50mg Per Day) (View Seloken Review and Seloken Label ), CORDARONE (200mg Per Day) (View Cordarone Review and Cordarone Label ), SMECTA (1bag Three Times Per Day) (View Smecta Review and Smecta Label ), ALLOPURINOL (300mg Per Day) (View Allopurinol Review and Allopurinol Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), BACTRIM (2tab Two Times Per Week) (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

4950523-1 | Venoocclusive Disease
on Mar 14, 2006 Female patient from IRELAND , child 1 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Lanvis (View Usage). After Lanvis was administered, patient had the following side effects: venoocclusive disease. Lanvis dosage: 30mg Per Day. During the same period patient was treated with CYTOSAR (41mg Per Day) (View Cytosar Review and Cytosar Label ), METHOTREXATE (8mg Per Day) (View Methotrexate Review and Methotrexate Label ).

4895266-8 | Histiocytosis Haematophagic, Pancytopenia, Venoocclusive Liver Disease
Patient was taking Lanvis (View Usage). Patient experienced the following unwanted or unexpected effects: histiocytosis haematophagic, pancytopenia, venoocclusive liver disease on Jan 18, 2006 from FRANCE Additional patient health information: Female patient , child 3 years of age, . Lanvis dosage: .

4889637-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Enzyme Increased, Prothrombin Level Decreased
Adverse event was reported on Jan 13, 2006 by a Male patient taking Lanvis (View Usage) (Dosage: 60mgm2 Per Day) was diagnosed with acute lymphocytic leukaemia and. Location: FRANCE , child 8 years of age, weighting 41.89 lb, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic enzyme increased, prothrombin level decreased. During the same period patient was treated with VINCRISTINE (View Vincristine Review and Vincristine Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), PURINETHOL (View Purinethol Review and Purinethol Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4881533-0 | Difficulty In Walking, Exfoliative Rash, Muscle Rigidity, Pain, Psoriasis, Pyrexia, Skin Disorder
on Jan 02, 2006 Male patient from SWEDEN , 39 years of age, was treated with Lanvis (View Usage). After Lanvis was administered, patient had the following side effects: difficulty in walking, exfoliative rash, muscle rigidity, pain (What is pain?), psoriasis, pyrexia, skin disorder. Lanvis dosage: 40mg Twice Per Day. During the same period patient was treated with ALVEDON (View Alvedon Review and Alvedon Label ), VOLTAREN (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

4878850-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Thromboplastin, Hepatic Enzyme Increased, Prealbumin Decreased
on Jan 03, 2006 Male patient from FINLAND , 48 years of age, was treated with Lanvis (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood thromboplastin, hepatic enzyme increased, prealbumin decreased. Lanvis dosage: 40mg Per Day. During the same period patient was treated with ASACOL (3200mg Per Day) (View Asacol Review and Asacol Label ).

4781256-2 | Cholecystitis, Hepatic Cirrhosis, Hepatic Function Abnormal, Pain, Platelet Count Decreased, Stomach Discomfort
Patient was taking Lanvis (View Usage). Patient had the following side effects: cholecystitis, hepatic cirrhosis, hepatic function abnormal, pain (What is pain?), platelet count decreased, stomach discomfort on Feb 06, 2004 from NETHERLANDS Additional patient health information: Male patient , 49 years of age, weighting 158.7 lb, was diagnosed with crohn's disease (What is crohn's disease?), malaria prophylaxis and. Lanvis dosage: . During the same period patient was treated with ATOVAQUONE + PROGUANIL HYDROCHLORIDE (1tab Per Day) (View Atovaquone + Proguanil Hydrochloride Review and Atovaquone + Proguanil Hydrochloride Label ), PREDNISON (5mg Per Day) (View Prednison Review and Prednison Label ), HYDROCOBAMINE (View Hydrocobamine Review and Hydrocobamine Label ), MICONAZOLE (View Miconazole Review and Miconazole Label ), BUSCOPAN (View Buscopan Review and Buscopan Label ), CODEINE (20mg As Required) (View Codeine Review and Codeine Label ), ERYTHROMYCIN (2tab Twice Per Day) (View Erythromycin Review and Erythromycin Label ), DICLOFENAC (100mg As Required) (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

4766007-X | Cholecystitis, Hepatic Cirrhosis, Hepatic Function Abnormal, Pain, Platelet Count Decreased, Stomach Discomfort
Adverse event was reported on Feb 06, 2004 by a Male patient taking Lanvis (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?), malaria prophylaxis and. Location: NETHERLANDS , 49 years of age, weighting 158.7 lb, After Lanvis was administered, patient had the following side effects: cholecystitis, hepatic cirrhosis, hepatic function abnormal, pain (What is pain?), platelet count decreased, stomach discomfort. During the same period patient was treated with PREDNISON (5mg Per Day) (View Prednison Review and Prednison Label ), ATOVAQUONE + PROGUANIL HYDROCHLORIDE (1tab Per Day) (View Atovaquone + Proguanil Hydrochloride Review and Atovaquone + Proguanil Hydrochloride Label ), HYDROCOBAMINE (View Hydrocobamine Review and Hydrocobamine Label ), MICONAZOLE (View Miconazole Review and Miconazole Label ), BUSCOPAN (View Buscopan Review and Buscopan Label ), CODEINE (20mg As Required) (View Codeine Review and Codeine Label ), ERYTHROMYCIN (2tab Twice Per Day) (View Erythromycin Review and Erythromycin Label ), DICLOFENAC (100mg As Required) (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.